Found 0 matching trials
UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
NAThe clinical trial was designed as a single-arm, open-label clinical study,...
Location
The Second Affiliated Hospital of Soochow University
A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma
PHASE2This is a single-arm, open-label study to evaluate the efficacy and safety ...
Status
Active Not Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
PHASE1This is an investigator-initiated, single-center, open-label study of C-CAR...
Location
The Affiliated Hospital of Qingdao University
A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy
PHASE1This is an open-label, single-arm Phase I/II clinical study to evaluate the...
Location
China-Japan Friendship Hospital
Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma
PHASE1The mail purpose of this study is to estimate the safety and the efficacy o...
Location
State Institution Minsk Scientific and Practical Center for Surgery, Transplantology, and Hematology
Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma
NAA single arm, open-label pilot study is designed to determine the safety, e...
Location
Xin Hua Hospital of Shanghai Jiao Tong University of Medicine
UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
PHASE1This is an investigator-initiated trial to evaluate the safety and efficacy...
Location
Changzhou No.2 People's Hospital
AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma
PHASE1Clinical Study on the Safety and Effectiveness of Autologous Hematopoietic ...
Location
The first affiliated hospital of medical college of zhejiang university
RN1201 Injection in the Treatment of Antibody-Mediated Diseases
PHASE1This single-arm, open-label exploratory trial aims to evaluate the safety, ...
Location
The First Affiliated Hospital of Soochow University
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
PHASE2The objective of this study is to evaluate the efficacy and safety of BCMA/...
Location
Department of Rheumatology and Immunology, Peking University People's Hospital